GeoVax Labs, Inc. , a biotechnology company developing vaccines to prevent and treat HIV/AIDS, announced its financial results for the six months ended June 30, 2013 and provided a clinical development update.
http://www.biospace.com/news_story.aspx?StoryID=305770&full=1
http://www.biospace.com/news_story.aspx?StoryID=305770&full=1
No comments:
Post a Comment